Mersana Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -8.83 | -100% |
| P/S |
|
6.36 | 33.76 | -81.15% |
|
|
| P/BV |
|
6.36 | 4.82 | 31.84% |
|
|
| P/FCF |
|
-0.8664 | 60.98 | -101.42% |
|
|
| Ev/Ebitda |
|
-0.5537 | -22.12 | -97.5% |
|
|
| Ev/S |
|
2.55 | 22.56 | -88.72% |
|
|
| Ev/FCF |
|
-0.5485 | 68.75 | -100.8% |
|
|
| E/P |
|
-1.16 | 0.0178 | -6626.5% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-459.75 | 4.83 | -9617.86% | -80890.78 | -99.43% |
| ROE |
|
-465.18 | 9.61 | -4942.52% |
|
|
| ROA |
|
-75.94 | 0.3359 | -22707.56% |
|
|
| ROIC |
|
-92.14 | 7.63 | -1306.91% |
|
|
| ROS |
|
-465.8 | -25.17 | 1750.61% |
|
|
| ROCE |
|
-463.25 | 15.33 | -3121.61% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.169 | -3.67 | -95.39% | -0.1688 | 0.0792% |
| Nеt Debt/Ebitda |
|
0.8306 | -3.44 | -124.15% |
|
|
| Debt/Ratio |
|
0.1266 | 0.1972 | -35.77% |
|
|
| Debt/Equity |
|
0.0897 | 1.65 | -94.55% |
|
|
| Debt/Net Income |
|
-0.1668 | 10.31 | -101.62% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% |
|
|
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
-12.46 | -56.89 | -78.1% |
| Growth impulse Ebitda 5 years |
|
505.14 | -64.81 | -879.42% |
| Growth impulse Net Income 5 years |
|
535.81 | -58.33 | -1018.58% |
| Growth impulse FCF 5 years |
|
150.44 | -47 | -420.09% |
| Growth impulse EPS 5 years |
|
138.46 | -32.41 | -527.21% |
IP Score
4.36/10
